This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Obesity Science & Innovation USA (OSI USA)
September 23-24, 2026
Hynes Convention CenterBoston, United States

Laura Holberger
Associate Director, R&D External Innovation Partners at Novo Nordisk
Speaker

Profile

Laura Holberger, PhD MBA is an external innovation and partnerships leader on Novo Nordisk’s R&D External Innovation team, focused on identifying and advancing collaborations to drive innovation in rare and chronic disease therapies. She previously held strategic roles across the biopharma ecosystem—including BioLabs, BioInnovation Capital, Cambridge Biolabs, and ViThera—working at the intersection of biotech, pharma, and investment. She holds degrees from WPI (B.Sc.), UC Santa Barbara (Ph.D.), and MIT (M.B.A.), and brings a practical, partnership first perspective to building effective collaborations.

Agenda Sessions

  • Keynote Panel: Partnerships In Focus – Essential Pharma and Investor “Must Haves”

    09:30